NCT03331900View on ClinicalTrials.gov

Study of COR388 HCl in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 11, 2017

Primary Completion Date

February 20, 2018

Study Completion Date

April 2, 2018

Conditions
Healthy Subjects
Interventions
DRUG

COR388

Administered as oral capsule

DRUG

Placebo

Administered as oral capsule

Trial Locations (1)

45227

Medpace Clinical Pharmacology Unit, Cincinnati

Sponsors

Lead Sponsor

Cortexyme Inc.
All Listed Sponsors
lead

Cortexyme Inc.

INDUSTRY

NCT03331900 - Study of COR388 HCl in Healthy Subjects | Biotech Hunter | Biotech Hunter